Xing J - Search Results

1

A single-domain antibody-linked Fab bispecific antibody Her2-S-Fab has potent cytotoxicity against Her2-expressing tumor cells.

Li A, Xing J, Li L, Zhou C, Dong B, He P, Li Q, Wang Z. Li A, et al. Among authors: xing j. AMB Express. 2016 Dec;6(1):32. doi: 10.1186/s13568-016-0201-4. Epub 2016 Apr 26. AMB Express. 2016. PMID: 27112931 Free PMC article.

2

BiHC, a T-Cell-Engaging Bispecific Recombinant Antibody, Has Potent Cytotoxic Activity Against Her2 Tumor Cells.

Xing J, Lin L, Li J, Liu J, Zhou C, Pan H, Shu R, Dong B, Cao D, Li Q, Wang Z. Xing J, et al. Transl Oncol. 2017 Oct;10(5):780-785. doi: 10.1016/j.tranon.2017.07.003. Epub 2017 Aug 7. Transl Oncol. 2017. PMID: 28797938 Free PMC article.

3

A targeted IL-15 fusion protein with potent anti-tumor activity.

Chen S, Huang Q, Liu J, Xing J, Zhang N, Liu Y, Wang Z, Li Q. Chen S, et al. Among authors: xing j. Cancer Biol Ther. 2015;16(9):1415-21. doi: 10.1080/15384047.2015.1071739. Epub 2015 Jul 15. Cancer Biol Ther. 2015. PMID: 26176990 Free PMC article.

4

Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy.

Pan H, Liu J, Deng W, Xing J, Li Q, Wang Z. Pan H, et al. Among authors: xing j. Int J Nanomedicine. 2018 May 29;13:3189-3201. doi: 10.2147/IJN.S164542. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29881272 Free PMC article.

5

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity.

Wang Y, Liu J, Pan H, Xing J, Wu X, Li Q, Wang Z. Wang Y, et al. Among authors: xing j. J Vis Exp. 2018 Jul 12;(137):57588. doi: 10.3791/57588. J Vis Exp. 2018. PMID: 30059039 Free PMC article.

6

A novel multifunctional anti-CEA-IL15 molecule displays potent antitumor activities.

Liu Y, Wang Y, Xing J, Li Y, Liu J, Wang Z. Liu Y, et al. Among authors: xing j. Drug Des Devel Ther. 2018 Aug 29;12:2645-2654. doi: 10.2147/DDDT.S166373. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30214153 Free PMC article.

7

Antitumor Effects and Mechanism of Novel Emodin Rhamnoside Derivatives against Human Cancer Cells In Vitro.

Xing JY, Song GP, Deng JP, Jiang LZ, Xiong P, Yang BJ, Liu SS. Xing JY, et al. PLoS One. 2015 Dec 18;10(12):e0144781. doi: 10.1371/journal.pone.0144781. eCollection 2015. PLoS One. 2015. PMID: 26682731 Free PMC article.

8

Nickel-Catalyzed Three-Component Carboamination/Cyclization of Alkynes To Access 2,3-Disubstituted Quinolines.

Gao Y, Xing J, Huo Y, Chen Q, Li X, Hashmi ASK, Zeng Z. Gao Y, et al. Among authors: xing j. Org Lett. 2025 Jan 23. doi: 10.1021/acs.orglett.4c04753. Online ahead of print. Org Lett. 2025. PMID: 39848257

9

Regulation of Zinc Hydroxide Sulfate Growth Environment for Stable Zinc Anode/Electrolyte Interfaces.

Huang K, Zeng X, Zhang D, Wen C, Lu C, Wu W, Guo Y, Xing J. Huang K, et al. Among authors: xing j. Langmuir. 2025 Jan 23. doi: 10.1021/acs.langmuir.4c04558. Online ahead of print. Langmuir. 2025. PMID: 39846231

10

Novel target and cofactor repertoire for the transcriptional regulator JTY_0672 from Mycobacterium bovis BCG.

Wang H, Li X, Wang S, Fang R, Xing J, Wu R, Zhang C, Li Z, Song N. Wang H, et al. Among authors: xing j. Front Microbiol. 2025 Jan 7;15:1464444. doi: 10.3389/fmicb.2024.1464444. eCollection 2024. Front Microbiol. 2025. PMID: 39845031 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,426 results

Search Page

Filters